118858668

Govt seeks nod for extra Rs 51,000 crore spend

NEW DELHI: Government on Monday sought Parliamentary approval for additional spending, including a cash outgo of over Rs 51,000 crore, with large chunks going towards fertiliser subsidy and pension. Over Rs 14,000 crore is proposed to be spent towards higher fertiliser subsidy, according to the second supplementary demand for grants tabled in Parliament.Permission to make…

Read More
118859049

Govt advertises for Irdai chief post

MUMBAI: Finance ministry has invited applications for the post of chairman of the Insurance Regulatory and Development Authority of India (Irdai), with the position set to fall vacant on March 13, 2025, after Debasish Panda’s tenure ends. The last date for submitting applications is April 6, 2025. Source link

Read More
118859111

Sebi tightens SME IPO norms with profitability need

NEW DELHI: Markets regulator Sebi has notified a stricter regulatory framework for small and medium enterprise (SME) IPOs by introducing a profitability requirement and capping a 20% limit on offer-for-sale (OFS). The reforms aim to provide SMEs with a sound track record an opportunity to raise funds from the public while protecting investor interests. This…

Read More
118859211

Nakajima is new CEO of Honda Cars India

NEW DELHI: Japanese automaker Honda on Monday said it had appointed Takashi Nakajima as the new president & CEO of Honda Cars India. He will take charge on April 1, 2025, from Takuya Tsumura, who will move to Japan at Honda head office after completing his India tenure. Nakajima has been serving as president of…

Read More
118858319

Sun Pharma to acquire US oncology compony for over Rs 3,000 crore

Sun Pharma, India’s largest drugmaker, is acquiring Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and targeted oncology company, for $355 million (over Rs 3,000 crore).The acquisition will bolster the company’s specialty portfolio.Checkpoint is a commercial-stage company that develops novel treatments for patients with solid tumor cancers, and the acquisition includes UNLOXCYT, an FDA-approved treatment for advanced skin…

Read More